United States · FDA National Drug Code directory
Ondansetron Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51655-415_4b42c5c3-2626-a1d3-e063-6294a90ab9d3
- Product NDC
- 51655-415
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ondansetron Hydrochloride
- Labeler
- Northwind Health Company, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171207
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 TABLET, FILM COATED in 1 BOTTLE (51655-415-04) · 51655-415-04
- 3 TABLET, FILM COATED in 1 BOTTLE (51655-415-43) · 51655-415-43
- 10 TABLET, FILM COATED in 1 BOTTLE (51655-415-53) · 51655-415-53
- 15 TABLET, FILM COATED in 1 BOTTLE (51655-415-54) · 51655-415-54
- 5 TABLET, FILM COATED in 1 BOTTLE (51655-415-55) · 51655-415-55
- 6 TABLET, FILM COATED in 1 BOTTLE (51655-415-87) · 51655-415-87
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →